Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

, UNH

UnitedHealth

$159.51

1.19 (0.75%)

09:56
12/01/16
12/01
09:56
12/01/16
09:56

UnitedHealth issues coverage policy for Sarepta's Exondys 51

UnitedHealth (UNH) has issued its Drug Policy, effective February 1, 2017, on Sarepta's (SRPT) Exondys 51, which states that eteplirsen may be covered for the treatment of Duchenne muscular dystrophy in patients who meet certain criteria. Shares of Sarepta Therapeutics (SRPT) are down 3% in early trading. Reference Link

SRPT

Sarepta

$34.26

-2.46 (-6.70%)

UNH

UnitedHealth

$159.51

1.19 (0.75%)

SRPT Sarepta
$34.26

-2.46 (-6.70%)

10/27/16
FBCO
10/27/16
NO CHANGE
Target $68
FBCO
Outperform
Sarepta reimbursement concerns overdone, says Credit Suisse
Credit Suisse analyst Alethia Young believes Sarepta Exondys 51 reimbursement concerns are "quite overdone" and notes payer negotiation is inline with what the company has seen in other rare disease drugs launch. Young rates Sarepta an Outperform with a $68 price target.
10/27/16
WEDB
10/27/16
NO CHANGE
Target $72
WEDB
Outperform
Sarepta selloff overdone, says Wedbush
Wedbush analyst Heather Behanna said the selloff in Sarepta is overdone and recommends shares ahead of the Exondys 51 launch update in January. The analyst has an Outperform rating and a $72 price target on Sarepta shares.
11/11/16
LEER
11/11/16
NO CHANGE
Target $55
LEER
Market Perform
Sarepta Exondys 51 launch expectations seem too high for 2017, says Leerink
Leerink analyst Joseph Schwartz believes Sarepta Exondys 51 launch expectations may be too high for 2017. While nothing that a true Duchenne muscular dystrophy prevalence remains unknown, the analyst says that a "start form" number of about 200 patients would need to be provided in early January in order for investors to be confident in 2017 consensus sales estimates of $215M. Additionally, Schwartz points out that based on the price of Exondys 51 per vial, it currently appears that management has underestimated the true price of the drug which they will realize.
11/29/16
BARD
11/29/16
NO CHANGE
Target $102
BARD
Outperform
Baird sees strong launch for Sarepta after surveying neurologists
After his firm surveyed 30 neurologists treating at least ten Duchenne muscular dystrophy patients and at least five suspected/confirmed patients amenable to exon-51 skipping, Baird analyst Brian Skorney believes Sarepta Therapeutics' Exondys 51 is positioned for a strong launch. In a research note earlier today, Skorney said that most of the 30 doctors surveyed seem convinced of the drug's efficacy, and plan to start prescribing the drug in the next year. The drug's consensus sales estimate for its first quarter on the market of $7.1M may be understating sales, Skorney wrote. The analyst continues to expect $11M of Exondys 51 sales in Q4. He has an Outperform rating on shares of Sarepta with a $102 price target. The stock is up 34c, or 1%, to $36.62 in morning trading.
UNH UnitedHealth
$159.51

1.19 (0.75%)

11/30/16
OPCO
11/30/16
NO CHANGE
Target $171
OPCO
Outperform
UnitedHealth price target raised to $171 from $161 at Oppenheimer
Oppenheimer analyst Michael Wiederhorn raised his price target for UnitedHealth to $171 from $161 on "strong" 2017 outlook buoyed by robust Medicare Advantage growth. The analyst believes the business is performing well, and could benefit from the changes in Washington given the GOP bias toward managed care. Wiederhorn reiterates an Outperform rating on the shares and says he would continue to be a buyer of the blue-chip name.
11/30/16
UBSW
11/30/16
NO CHANGE
Target $193
UBSW
Buy
UnitedHealth price target raised to $193 from $180 at UBS
UBS analyst A.J. Rice raised his price target on UnitedHealth to $193 from $180 following its very positive investor day. The company said they see strong growth driven by both group and individual markets while controlling their commercial medical cost trend, noted Rice, who reiterated his Buy rating on UnitedHealth shares.
11/30/16
COWN
11/30/16
NO CHANGE
Target $175
COWN
Outperform
UnitedHealth price target raised to $175 from $150 at Cowen
Cowen analyst Christine Arnold raised her price target on UnitedHealth to $175 from $150 reflecting the company's guidance provided at its analyst day.The analyst said UnitedHealth remains a top pick for 2017 as it has an abundance of tailwinds and minimal company-specific headwinds. Arnold reiterated her Outperform rating on UnitedHealth shares.
11/30/16
SBSH
11/30/16
NO CHANGE
Target $178
SBSH
Buy
UnitedHealth price target raised to $178 after analyst day at Citi
Citi analyst Ralph Giacobbe said UnitedHealth's "upbeat tone" at its investor day matched the company's "impressive" 2017 guidance, saying the company remains in an enviable position of having size, scale, and infrastructure to invest while expanding its reach via Optum. Giacobbe raised his price target on UnitedHealth shares to $178 from $164 and keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

TIF

Tiffany

$92.31

0.52 (0.57%)

06:38
06/27/17
06/27
06:38
06/27/17
06:38
Recommendations
Tiffany analyst commentary  »

Tiffany added to US 1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$32.50

0.77 (2.43%)

06:36
06/27/17
06/27
06:36
06/27/17
06:36
Hot Stocks
Micron exploring sale of discontinued Lexar business »

Micron Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 29

    Aug

MON

Monsanto

$117.80

0.78 (0.67%)

06:33
06/27/17
06/27
06:33
06/27/17
06:33
Downgrade
Monsanto rating change  »

Monsanto downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

FMSA

Fairmount Santrol

$3.68

-0.05 (-1.34%)

06:32
06/27/17
06/27
06:32
06/27/17
06:32
Downgrade
Fairmount Santrol rating change  »

Fairmount Santrol…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$41.55

0.9 (2.21%)

06:32
06/27/17
06/27
06:32
06/27/17
06:32
Hot Stocks
S&P affirms Assured Guaranty's AA financial strength ratings with stable outlook »

Assured Guaranty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FET

Forum Energy

06:32
06/27/17
06/27
06:32
06/27/17
06:32
Downgrade
Forum Energy rating change  »

Forum Energy downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$65.89

-0.04 (-0.06%)

06:32
06/27/17
06/27
06:32
06/27/17
06:32
Downgrade
Schlumberger rating change  »

Schlumberger downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

HP

Helmerich & Payne

$53.16

0.42 (0.80%)

06:32
06/27/17
06/27
06:32
06/27/17
06:32
Downgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPN

Superior Energy

$9.78

0.04 (0.41%)

06:31
06/27/17
06/27
06:31
06/27/17
06:31
Downgrade
Superior Energy rating change  »

Superior Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBR

Nabors Industries

$7.93

0.06 (0.76%)

06:31
06/27/17
06/27
06:31
06/27/17
06:31
Downgrade
Nabors Industries rating change  »

Nabors Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHI

Baker Hughes

$53.70

-0.29 (-0.54%)

06:31
06/27/17
06/27
06:31
06/27/17
06:31
Downgrade
Baker Hughes rating change  »

Baker Hughes downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PI

Impinj

$59.37

0.58 (0.99%)

06:31
06/27/17
06/27
06:31
06/27/17
06:31
Downgrade
Impinj rating change  »

Impinj downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GEF

Greif

$55.51

-0.1 (-0.18%)

06:29
06/27/17
06/27
06:29
06/27/17
06:29
Conference/Events
Greif to host investor breakfast day »

Investor Breakfast Day to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

UAA

Under Armour

$21.56

0.36 (1.70%)

, UA

Under Armour

$19.92

0.27 (1.37%)

06:27
06/27/17
06/27
06:27
06/27/17
06:27
Recommendations
Under Armour, Under Armour, Kohl's, Nike, adidas analyst commentary  »

Under Armour still…

UAA

Under Armour

$21.56

0.36 (1.70%)

UA

Under Armour

$19.92

0.27 (1.37%)

KSS

Kohl's

$37.52

0.49 (1.32%)

NKE

Nike

$53.28

0.43 (0.81%)

ADDYY

adidas

$94.38

-0.015 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

LYV

Live Nation

$34.86

0.02 (0.06%)

06:20
06/27/17
06/27
06:20
06/27/17
06:20
Recommendations
Live Nation analyst commentary  »

Live Nation price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLT

Hilton

$65.23

-0.17 (-0.26%)

, CHH

Choice Hotels

$66.25

-0.45 (-0.67%)

06:17
06/27/17
06/27
06:17
06/27/17
06:17
Recommendations
Hilton, Choice Hotels, Hyatt, Marriott analyst commentary  »

Deutsche…

HLT

Hilton

$65.23

-0.17 (-0.26%)

CHH

Choice Hotels

$66.25

-0.45 (-0.67%)

H

Hyatt

$58.09

0.39 (0.68%)

MAR

Marriott

$103.93

-0.13 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

GOOGL

Alphabet Class A

$972.09

-14 (-1.42%)

06:14
06/27/17
06/27
06:14
06/27/17
06:14
Technical Analysis
Technical View: Alphabet Class A falls after EU fine, potential bearish pattern »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSUR

OraSure

$15.72

0.17 (1.09%)

06:10
06/27/17
06/27
06:10
06/27/17
06:10
Hot Stocks
OraSure's HIV self-test supported by Gates Foundation for accelerated adoption »

OraSure entered a new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

BABA

Alibaba

$142.73

-0.28 (-0.20%)

06:09
06/27/17
06/27
06:09
06/27/17
06:09
Initiation
Alibaba initiated  »

Alibaba resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

RDWR

Radware

$17.94

-0.04 (-0.22%)

06:06
06/27/17
06/27
06:06
06/27/17
06:06
Hot Stocks
Radware granted ISO27017 and ISO27018 cloud services certifications »

Radware has achieved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

  • 13

    Jul

GRPN

Groupon

$3.45

-0.02 (-0.58%)

06:06
06/27/17
06/27
06:06
06/27/17
06:06
Recommendations
Groupon analyst commentary  »

Groupon trading well…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDS

GDS Holdings

$8.83

-0.22 (-2.43%)

, BABA

Alibaba

$142.73

-0.28 (-0.20%)

06:05
06/27/17
06/27
06:05
06/27/17
06:05
Hot Stocks
GDS Holdings announces new order from Alibaba for Beijing 3 data center »

GDS Holdings (GDS)…

GDS

GDS Holdings

$8.83

-0.22 (-2.43%)

BABA

Alibaba

$142.73

-0.28 (-0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MCK

McKesson

$167.61

0.65 (0.39%)

06:04
06/27/17
06/27
06:04
06/27/17
06:04
Conference/Events
McKesson to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 26

    Jul

  • 30

    Jul

INFO

IHS Markit

$46.40

-0.15 (-0.32%)

06:04
06/27/17
06/27
06:04
06/27/17
06:04
Earnings
IHS Markit sees FY17 adjusted EPS $2.02-$2.08, consensus $2.06 »

Sees FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

UCBI

United Community Banks

$26.70

0.22 (0.83%)

, FOFN

Four Oaks Fincorp

$15.18

0.4 (2.71%)

06:03
06/27/17
06/27
06:03
06/27/17
06:03
Hot Stocks
United Community, Banks Four Oaks Fincorp announce merger agreement »

Community Banks (UCBI)…

UCBI

United Community Banks

$26.70

0.22 (0.83%)

FOFN

Four Oaks Fincorp

$15.18

0.4 (2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.